Novel KPC-2 Plasmid in a Clinical Salmonella Rissen Selected by Antibiotic Pressure.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 41103243.
- Also identified by DOI 10.1093/infdis/jiaf536.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this work, we present the genomic characterization of a clinical Salmonella enterica serovar Rissen isolate harboring a novel IncN2 plasmid carrying the blaKPC-2 gene. The identified plasmid (pSEay-KPC) also encoded additional resistance genes, including blaACC-1, blaTEM-1, and qnrB. The pSEay-KPC conferred broad-spectrum antimicrobial resistance, allowing the pathogen to survive two consecutive antibiotic therapies with ceftriaxone and ciprofloxacin. Effective treatment was ultimately achieved with meropenem-vaborbactam, a last-resort agent. These findings highlight IncN2 plasmids as potent vectors for the spread of clinically significant resistance genes, enabling bacteria to evade frontline antimicrobials and complicating infection management.
Medical subject headings
- Plasmids
- Anti-Bacterial Agents
- beta-Lactamases
- Salmonella enterica
- Salmonella Infections
- Drug Resistance, Multiple, Bacterial